439 related articles for article (PubMed ID: 27196571)
1. Opposite roles of cannabinoid receptors 1 and 2 in hepatocarcinogenesis.
Suk KT; Mederacke I; Gwak GY; Cho SW; Adeyemi A; Friedman R; Schwabe RF
Gut; 2016 Oct; 65(10):1721-32. PubMed ID: 27196571
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of fatty acid amide hydrolase exacerbates experimental fibrosis by enhanced endocannabinoid-mediated activation of CB1.
Palumbo-Zerr K; Horn A; Distler A; Zerr P; Dees C; Beyer C; Selvi E; Cravatt BF; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2012 Dec; 71(12):2051-4. PubMed ID: 22915616
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma.
Xu X; Liu Y; Huang S; Liu G; Xie C; Zhou J; Fan W; Li Q; Wang Q; Zhong D; Miao X
Cancer Genet Cytogenet; 2006 Nov; 171(1):31-8. PubMed ID: 17074588
[TBL] [Abstract][Full Text] [Related]
4. New Insights of Uterine Leiomyoma Pathogenesis: Endocannabinoid System.
Ayakannu T; Taylor AH; Marczylo TH; Konje JC
Med Sci Monit Basic Res; 2019 Mar; 25():76-87. PubMed ID: 30842391
[TBL] [Abstract][Full Text] [Related]
5. Changes in the expression of endocannabinoid system components in an experimental model of chemotherapy-induced peripheral neuropathic pain: Evaluation of sex-related differences.
Noya-Riobó MV; Miguel CÁ; Soriano DB; Brumovsky PR; Villar MJ; Coronel MF
Exp Neurol; 2023 Jan; 359():114232. PubMed ID: 36179876
[TBL] [Abstract][Full Text] [Related]
6. Role of the endocannabinoid system in the mechanisms involved in the LPS-induced preterm labor.
Bariani MV; Domínguez Rubio AP; Cella M; Burdet J; Franchi AM; Aisemberg J
Reproduction; 2015 Dec; 150(6):463-72. PubMed ID: 26347521
[TBL] [Abstract][Full Text] [Related]
7. The expression of receptors for endocannabinoids in human and rodent skeletal muscle.
Cavuoto P; McAinch AJ; Hatzinikolas G; Janovská A; Game P; Wittert GA
Biochem Biophys Res Commun; 2007 Dec; 364(1):105-10. PubMed ID: 17935697
[TBL] [Abstract][Full Text] [Related]
8. [Membrane cholesterol mediates the endocannabinoids-anandamide affection on HepG2 cells].
Wu WJ; Yang Q; Cao QF; Zhang YW; Xia YJ; Hu XW; Tang WX
Zhonghua Gan Zang Bing Za Zhi; 2010 Mar; 18(3):204-8. PubMed ID: 20380798
[TBL] [Abstract][Full Text] [Related]
9. Endocannabinoid System Contributes to Liver Injury and Inflammation by Activation of Bone Marrow-Derived Monocytes/Macrophages in a CB1-Dependent Manner.
Mai P; Yang L; Tian L; Wang L; Jia S; Zhang Y; Liu X; Yang L; Li L
J Immunol; 2015 Oct; 195(7):3390-401. PubMed ID: 26320250
[TBL] [Abstract][Full Text] [Related]
10. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice.
Nozaki C; Markert A; Zimmer A
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1388-96. PubMed ID: 25910421
[TBL] [Abstract][Full Text] [Related]
12. Effects of endocannabinoid and endovanilloid systems on aversive memory extinction.
Laricchiuta D; Centonze D; Petrosini L
Behav Brain Res; 2013 Nov; 256():101-7. PubMed ID: 23948212
[TBL] [Abstract][Full Text] [Related]
13. Localization of cannabinoid receptors CB1, CB2, GPR55, and PPARα in the canine gastrointestinal tract.
Galiazzo G; Giancola F; Stanzani A; Fracassi F; Bernardini C; Forni M; Pietra M; Chiocchetti R
Histochem Cell Biol; 2018 Aug; 150(2):187-205. PubMed ID: 29882158
[TBL] [Abstract][Full Text] [Related]
14. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.
Desroches J; Charron S; Bouchard JF; Beaulieu P
Neuropharmacology; 2014 Feb; 77():441-52. PubMed ID: 24148808
[TBL] [Abstract][Full Text] [Related]
15. Distribution and function of the endocannabinoid system in the rat and human bladder.
Bakali E; Elliott RA; Taylor AH; Willets J; Konje JC; Tincello DG
Int Urogynecol J; 2013 May; 24(5):855-63. PubMed ID: 23081739
[TBL] [Abstract][Full Text] [Related]
16. Hepatic expression of cannabinoid receptors CB1 and CB2 correlate with fibrogenesis in patients with chronic hepatitis B.
Dai E; Zhang L; Ye L; Wan S; Feng L; Qi Q; Yao F; Li Z
Int J Infect Dis; 2017 Jun; 59():124-130. PubMed ID: 28315398
[TBL] [Abstract][Full Text] [Related]
17. The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain.
Malek N; Kostrzewa M; Makuch W; Pajak A; Kucharczyk M; Piscitelli F; Przewlocka B; Di Marzo V; Starowicz K
Pharmacol Res; 2016 Sep; 111():251-263. PubMed ID: 27326920
[TBL] [Abstract][Full Text] [Related]
18. n-3 polyunsaturated N-acylethanolamines are CB
Alharthi N; Christensen P; Hourani W; Ortori C; Barrett DA; Bennett AJ; Chapman V; Alexander SPH
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Nov; 1863(11):1433-1440. PubMed ID: 30591150
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis.
Benito C; Romero JP; Tolón RM; Clemente D; Docagne F; Hillard CJ; Guaza C; Romero J
J Neurosci; 2007 Feb; 27(9):2396-402. PubMed ID: 17329437
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid receptor antagonists and fatty acids alter endocannabinoid system gene expression and COX activity.
Kim J; Watkins BA
J Nutr Biochem; 2014 Aug; 25(8):815-23. PubMed ID: 24854955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
